(Q37942363)

25 August 2017

1 reference

title

Peri-interventional coronary vasomotion (English)

1 reference

25 August 2017

Luisa Gregorini

1

1 reference

25 August 2017

Jean Marco

series ordinal

2

1 reference

25 August 2017

Gerd Heusch

series ordinal

3

1 reference

25 August 2017

publication date

24 September 2011

1 reference

Journal of Molecular and Cellular Cardiology

25 August 2017

published in

1 reference

25 August 2017

volume

52

1 reference

25 August 2017

issue

4

1 reference

25 August 2017

page(s)

883-889

1 reference

Cholesterol potentiates the coronary artery response to norepinephrine in anesthetized and conscious dogs

25 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.09.017

The paradox of α-adrenergic coronary vasoconstriction revisited

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.09.017

Alpha-adrenergic mechanisms in myocardial ischemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.09.017

The effects of cardiac sympathetic nerve stimulation on perfusion of stenotic coronary arteries in the dog.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.09.017

Functional distribution of alpha 1- and alpha 2-adrenergic receptors in the coronary microcirculation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.09.017

A sympathetic reflex elicited by experimental coronary occlusion

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.09.017

Cardiac sympathetic nerve activity and progressive vasoconstriction distal to coronary stenoses: feed-back aggravation of myocardial ischemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.09.017

Neuronal control of coronary blood flow.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.09.017

Neural control of coronary blood flow.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.09.017

Delineation of the distribution of beta-adrenergic receptor subtypes in canine myocardium

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.09.017

Role of beta2 adrenergic receptors in human atherosclerotic coronary arteries

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.09.017

Coronary vasoconstriction after percutaneous transluminal coronary angioplasty is attenuated by antiadrenergic agents

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.09.017

Postischemic Left Ventricular Dysfunction Is Abolished by Alpha-Adrenergic Blocking Agents 11This study was supported by institutional funds from the University of Milan (MURST 60%). Hewlett Packard Germany provided the echocardiographic equipment us

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.09.017

Alpha-adrenergic blockade improves recovery of myocardial perfusion and function after coronary stenting in patients with acute myocardial infarction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.09.017

Effects of selective alpha1- and alpha2-adrenergic blockade on coronary flow reserve after coronary stenting

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.09.017

Coronary artery vasoconstriction routinely occurs after percutaneous transluminal coronary angioplasty. A quantitative arteriographic analysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.09.017

Impaired coronary blood flow in nonculprit arteries in the setting of acute myocardial infarction. The TIMI Study Group. Thrombolysis in myocardial infarction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.09.017

Stenting for elastic recoil during coronary angioplasty of the left main coronary artery

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.09.017

Quantitative analysis of elastic recoil after balloon angioplasty and after intracoronary implantation of balloon-expandable Palmaz-Schatz stents

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.09.017

Abnormal coronary flow velocity reserve after coronary artery stenting in patients: role of relative coronary reserve to assess potential mechanisms

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.09.017

Adenosine and maximum coronary vasodilation in humans: myth and misconceptions in the assessment of coronary reserve

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.09.017

Effects of droperidol on sympathetic activity and baroreflex control of heart rate in humans

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.09.017

Specific α-adrenoceptor blocking effect of droperidol on isolated smooth muscles

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.09.017

Augmented alpha-adrenergic constriction of atherosclerotic human coronary arteries

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.09.017

Impaired myocardial tissue perfusion early after successful thrombolysis. Impact on myocardial flow, metabolism, and function at late follow-up

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.09.017

Potential benefits of late reperfusion of infarcted myocardium. The open artery hypothesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.09.017

TIMI frame count: a quantitative method of assessing coronary artery flow

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.09.017

Reduction in acute myocardial infarction mortality in the United States: risk-standardized mortality rates from 1995-2006.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.09.017

The "no-reflow" phenomenon after temporary coronary occlusion in the dog.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.09.017

Unstable angina with fatal outcome: dynamic coronary thrombosis leading to infarction and/or sudden death. Autopsy evidence of recurrent mural thrombosis with peripheral embolization culminating in total vascular occlusion

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.09.017

Scintigraphic evidence of the "no reflow" phenomenon in human beings after coronary thrombolysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.09.017

Intense microvascular constriction after angioplasty of acute thrombotic coronary arterial lesions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.09.017

Progressive failure of coronary flow during reperfusion of myocardial infarction: documentation of the no reflow phenomenon with positron emission tomography

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.09.017

Recognition of the importance of embolization in atherosclerotic vascular disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.09.017

Coronary microembolization

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.09.017

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.09.017

Coronary microembolization

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.09.017

Coronary microembolization: from bedside to bench and back to bedside

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.09.017

Microvascular obstruction: underlying pathophysiology and clinical diagnosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.09.017

Vasoconstrictor potential of coronary aspirate from patients undergoing stenting of saphenous vein aortocoronary bypass grafts and its pharmacological attenuation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.09.017

Diagnostic discrimination between graft-related and non-graft-related perioperative myocardial infarction with cardiac troponin I after coronary artery bypass surgery.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.09.017

Adverse cerebral outcomes after coronary bypass surgery. Multicenter Study of Perioperative Ischemia Research Group and the Ischemia Research and Education Foundation Investigators.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.09.017

The decrease of plaque volume during percutaneous coronary intervention has a negative impact on coronary flow in acute myocardial infarction: a major role of percutaneous coronary intervention-induced embolization.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.09.017

Impact of atherosclerotic plaque composition on coronary microembolization during percutaneous coronary interventions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.09.017

Treatment of no-reflow in degenerated saphenous vein graft interventions: comparison of intracoronary verapamil and nitroglycerin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.09.017

The coronary no-reflow phenomenon: a review of mechanisms and therapies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.09.017

Treatment of no-reflow and impaired flow with the nitric oxide donor nitroprusside following percutaneous coronary interventions: initial human clinical experience

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.09.017

Coronary hyperemic dose responses of intracoronary sodium nitroprusside

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.09.017

Effect of glycoprotein IIb/IIIa receptor blockade on recovery of coronary flow and left ventricular function after the placement of coronary-artery stents in acute myocardial infarction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.09.017

High-dose intracoronary adenosine for myocardial salvage in patients with acute ST-segment elevation myocardial infarction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.09.017

The alpha-1 adrenergic blocking agent urapidil counteracts postrotational atherectomy "elastic recoil" where nitrates have failed

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.09.017

alpha-adrenergic coronary vasoconstriction and myocardial ischemia in humans

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.09.017

10.1016/J.YJMCC.2011.09.017

7 January 2021

Identifiers

DOI

1 reference

25 August 2017

1 reference